Cis-aconitate decarboxylase (ACOD1) in PMN-MDSC and prostate cancer progression
顺乌头酸脱羧酶 (ACOD1) 在 PMN-MDSC 和前列腺癌进展中的作用
基本信息
- 批准号:10560268
- 负责人:
- 金额:$ 37.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-01-18 至 2027-12-31
- 项目状态:未结题
- 来源:
- 关键词:Aconitic AcidAffectAllograftingAnti-Inflammatory AgentsAntiandrogen TherapyAntimicrobial EffectAttenuatedAutomobile DrivingCD8-Positive T-LymphocytesCancer BiologyCancer PatientCarboxy-LyasesCaringCell physiologyCellsCitric Acid CycleClassificationClinical ResearchCytometryDataGenesGeneticGenetic EngineeringGleason Grade for Prostate CancerHumanIL6 geneImageImmuneImmunomodulatorsImmunosuppressionImpairmentKnock-outMacrophageMalignant NeoplasmsMalignant neoplasm of prostateMammalian CellMediatingMetabolicModelingMolecularMusMyeloid-derived suppressor cellsNeoplasm MetastasisPathologicPatientsPlayPopulationPre-Clinical ModelPrimary NeoplasmProductionProstatic NeoplasmsRegulatory PathwayResistanceRoleSTAT3 geneSuccinatesT cell infiltrationTNF geneTestingTumor PromotionWorkadvanced prostate cancercancer typecastration resistant prostate cancercheckpoint therapyclinically relevantgranulocyteimmune resistanceimprovedmelanomametabolomicsmonocytemouse modelmultiple datasetsneutrophilnovelpharmacologicpreclinical studyprostate cancer modelprostate cancer progressionrecruitresponsesingle-cell RNA sequencingsuccesstherapeutic targettherapy resistanttranscriptometranscriptome sequencingtreatment responsetumortumor microenvironmenttumor progression
项目摘要
PROJECT SUMMARY/ABSTRACT
Immune checkpoint therapy (ICT) has revolutionized the care of several malignancies, resulting in durable
response and even cure in a small subset of cancer patients. However, unlike tumors that are highly responsive
to ICT (e.g., melanoma), the majority of patients with advanced prostate cancer respond poorly to ICT and no
survival benefits have been observed in non-selective patients. Although recent preclinical and clinical studies
have shed some light on the mechanisms of immunoresistance in prostate cancer, the cellular and molecular
basis of immunoresistance in prostate cancer remains poorly characterized.
Myeloid-derived suppressor cells (MDSCs), a group of pathologically activated monocytes and
neutrophils with potent immunosuppressive activities, have been implicated as one of the key mechanisms in
driving tumor progression, metastasis, and therapeutic resistance, including resistance to ICT, in various
cancers. MDSCs can be classified as polymorphonuclear or granulocytic MDSCs (PMN-MDSCs or G-MDSCs)
or monocytic MDSCs (M-MDSCs), with PMN-MDSCs as the predominant population in most cancer types. We
and others have demonstrated that PMN-MDSCs are the major MDSC subset in mouse and human prostate
cancers, playing an important role in prostate cancer progression and resistance to anti-androgen therapy and
ICT. Correspondingly, therapeutically targeting MDSCs delays prostate cancer progression and improves
responses to anti-androgen therapy and ICT in preclinical models. Importantly, PMN-MDSCs may be clinically
relevant to prostate cancer, as they are abundantly present in both primary and metastatic tumors.
Emerging evidence suggests that metabolic reprogramming of PMN-MDSCs plays an important role in
their immunosuppressive activities, yet the underlying molecular mechanisms are still poorly defined. Through
transcriptome analyses (single-cell RNA-seq, microarray, and bulk RNA-seq) of multiple datasets, we identified
Acod1, which encodes cis-aconitate decarboxylase (ACOD1), as one of the most highly expressed metabolic
genes in immunosuppressive PMN-MDSCs. ACOD1, which catalyzes the synthesis of itaconate from cis-
aconitate in the tricarboxylic acid (TCA) cycle, is a novel immunomodulator with potent anti-inflammatory and
antimicrobial effects in mammalian cells, especially in macrophages. Our results unexpectedly showed that
ACOD1 may also be a potential regulator of PMN-MDSCs. We hypothesize that ACOD1 promotes tumor
progression and resistance to ICT in prostate cancer through metabolic reprogramming of PMN-MDSCs. We will
test our hypothesis in the following aims: Aim 1). Determine the role of ACOD1 in regulating the
immunosuppressive activities of PMN-MDSCs. Aim 2). Determine the role of ACOD1 in PMN-MDSCs in driving
prostate cancer progression. Aim 3). Determine whether Acod1 KO improves the response of prostate cancer to
ICT.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Guocan Wang其他文献
Guocan Wang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Guocan Wang', 18)}}的其他基金
MDSC-tumor crosstalk in prostate cancer progression and castration resistance
MDSC-肿瘤串扰在前列腺癌进展和去势抵抗中的作用
- 批准号:
9109989 - 财政年份:2016
- 资助金额:
$ 37.06万 - 项目类别:
相似海外基金
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 37.06万 - 项目类别:
Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 37.06万 - 项目类别:
Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 37.06万 - 项目类别:
Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 37.06万 - 项目类别:
Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 37.06万 - 项目类别:
Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 37.06万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 37.06万 - 项目类别:
Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
- 批准号:
2301846 - 财政年份:2023
- 资助金额:
$ 37.06万 - 项目类别:
Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 37.06万 - 项目类别:
Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
- 批准号:
23K16076 - 财政年份:2023
- 资助金额:
$ 37.06万 - 项目类别:
Grant-in-Aid for Early-Career Scientists